APLS Apellis Pharmaceuticals47.69+0.18 (+0.4%)
APLS Apellis Pharmaceuticals47.65-0.38 (-0.8%)
APLS Apellis Pharmaceuticals51.69-4.04 (-7.3%)
Premarket Decliner
APLS Apellis Pharmaceuticals71.73+3.26+4.8%
Premarket:68.23-3.50 (-4.9%)
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Globe NewswireTue, 27-Feb 7:05 AM
APLS Apellis Pharmaceuticals62.41+2.31 (+3.8%)